(Q75410465)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14761802%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

title

Is pharmaceutical R&D just a game of chance or can strategy make a difference? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14761802%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

author name string

Esther F Schmid

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14761802%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

Dennis A Smith

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14761802%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14761802%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14761802%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14761802%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14761802%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

page(s)

18-26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14761802%20AND%20SRC:MED&resulttype=core&format=json

Stategic trends in the drug industry

18 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2902951-4

7 January 2021

Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2902951-4

7 January 2021

Discovery, innovation and the cyclical nature of the pharmaceutical business

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2902951-4

7 January 2021

New estimates of drug development costs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2902951-4

7 January 2021

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2902951-4

7 January 2021

The emerging importance of predictive ADME simulation in drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2902951-4

7 January 2021

10.1016/S1359-6446(04)02951-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14761802%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

1 reference